Targeting of macrophage activity by adenovirus-mediated intragraft overexpression of TNFRp55-Ig, IL-12p40, and vIL-10 ameliorates adenovirus-mediated chronic graft injury, whereas stimulation of macrophages by overexpression of IFN-γ accelerates chronic graft injury in a rat renal allograft model

Journal of the American Society of Nephrology

Volumn 14, Issue 1, 2003, Pages 214-225

  Yang, Jun ^a   Reutzel Selke, Anja ^a   Steier, Christoph ^a   Jurisch, Anke ^a   Günter Tullius, Stefan ^a   Sawitzki, Birgit ^a   Kolls, Jay ^b   Volk, Hans Dieter ^a   Ritter, Thomas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR RECEPTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC GRAFT REJECTION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FOLLOW UP; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNOCOMPETENT CELL; IMMUNOHISTOLOGY; IMMUNOREGULATION; KIDNEY ALLOGRAFT; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 12244259675     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000037703.73850.72     Document Type: Article

References (40)

1. Häyry P, Avavik E, and Savolainen: Mechanisms of chronic rejection. Transplant Proc 31: 5S-8S, 1999
2. Azuma H, Tilney NL: Chronic graft reiection. Curr Opin Iminunol 6: 770-776, 1994
3. Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Yard B, Kirchengast M, Tullius SG, Schnulle P, van der Woude FJ, Rohmeiss P: Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Transplantation 68: 739-746, 1999
4. Azuma H, Nadeau KC, Ishibashi M, Tilney NL: Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation 60: 1577-1582, 1995
5. Ode-Hakim S, Docke WD, Kern F, Emmrich F, Volk HD, Reinke P: Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipients. Transplantation 61: 1233-1240, 1996
6. Grenz A, Schenk M, Zipfel A, Viebahn R: TNF-alpha and its receptors mediate graft rejection and loss after liver transplantation. Clin Chem Lab Med 38: 1183-1185, 2000
7. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct celluar responses. Proc Natl Acad Sci USA 88: 9292-9296, 1991
8. Zhang HG, Zhou T, Yang P, Edwards CK 3rd, Curiel DT, Mountz JD: Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum Gene Ther 9: 1875-1884, 1998
9. Ritter T, Schroder G, Risch K, Vergopoulos A, Shean MK, Kolls J, Brock J, Lehmann M, Volk HD: Ischemia/reperfusion injurymediated down-regulation of adenovirus-mediated gene expression in a rat heart transplantation model is inhibited by coapplication of a TNFRp-55Ig chimeric construct. Gene Ther 7: 1238-1243, 2000
10. Scott P: IL-12: Initiation cytokine for cell-mediated immunity. Science 260: 496-497, 1993
11. Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzky AG, Quinn PM, Familletti PC, et al: Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A 88: 4143-4147, 1991
12. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U: Regulation of human lymphocyte proliferation by a heterodemeric cytokine, IL-12. J Immunol 147: 874-882, 1991
13. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK: Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist. Eur J Immunol 23: 200-206, 1995
14. Kato K, Shimozato O, Hoshi K, Wakimoto H, Hamada H, Yagita H, Okumura K: Local production of the p40 subunit of interleukin-12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci USA 93: 9085-9089, 1996
15. Mosmann, TR: Interleuklin-10. In: Cytokine Handbook, 2nd Ed., edited by Thomson AW, San Diego, Academic Press, 1994, pp 223-237
16. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 174: 915-924, 1991
17. Qin L, Ding Y, Pahud DR, Robson ND, Shaked A, Bromberg JS: Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 8: 1365-1374, 1997
18. Nagano H, Mitchell RN, Taylor MK, Hasegawa S, Tilney NL, Libby P: Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts J Clin Invest 100: 550-557, 1997
19. Konieczny BT, Dai Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK, Larsen CP, Pearson TC, Lakkis FG: IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 160: 2059-2064, 1998
20. Halloran PF, Afrouzian M, Ramassar V, Urmson J, Zhu LF, Helms LM, Solez K, Kneteman NM: Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol 158: 215-226, 2001
21. Gojo S, Cooper DK, Iacomini J, LeGuern C: Gene therapy and transplantation. Transplantation 69: 1995-1999, 2000
22. Guillot C, Le Mauff B, Cuturi MC, Anegon I: Gene therapy in transplantation in the year 2000: Moving towards clinical applications? Gene Ther 7: 14-19, 2000
23. Ritter T, Risch K, Schroder G, Kolls J, Siegling A, Graser E, Reinke P, Brock J, Lehmann M, Volk HD: Intragraft overexpression of interleukin-4 is neither sufficient nor essential for tolerance induction to cardiac allografts in a high-responder strain combination. Transplantation 68: 1427-1431, 1999
24. Kato H, Ritter T, Ke B, Murakami M, Kusano M, Busuttil RW, Kupiec-Weglinski JW: Adenovirus-mediated gene transfer of IL-4 prolongs rat allograft survival and inhibits the p21(ras)-activation pathway. Transplant Proc 32: 245-246, 2000
25. Qin L, Ding Y, Pahud DR, Robson ND, Shaked A, Bromberg JS: Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 8: 1365-1374, 1997
26. David A, Chetritt J, Guillot C, Tesson L, Heslan JM, Cuturi MC, Soulillou JP, Anegon I: Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther 7: 505-510, 2000
27. Kato H, Fieblinger C, Ke B, Li J, Volk HD, Busuttil RW, Kupiec-Weglinski JW, Ritter T: Synergistic effects of cytokine gene transfer in high responder rat renal allograft recipients. [Abstract]. Transplantation 67: S570, 1999
28. Lee S: An improved technique of renal transplantation in the rat. Surgery 61: 771-773, 1967
29. Ritter T, Vogt K, Rieck P, Schilling-Schon A, Kolls J, Hartmann C, Volk HD, Pleyer U: Adenovirus-mediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res 69: 563-568, 1999
30. Kolls J, Peppel K, Silva M, Beutler B: Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 91: 215-219, 1994
31. Schroder G, Risch K, Nizze H, Kolls J, Reinke P, Brock J, Lehmann M, Volk HD, Ritter T: Immune response after adenoviral gene transfer in syngeneic heart transplants: Effects of anti-CD4 monoclonal antibody therapy. Transplantation 70: 191-198, 2000
32. Sundt TM 3rd, Sachs DH: Application of molecular biology to transplantation tolerance. Immunol Today 9: 342-344, 1988
33. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, Kupiec-Weglinski JW: Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104: 1631-1639, 1999
34. Qin L, Ding Y, Bromberg JS: Use of gene therapy for tolerogenic signals. Transplant Proc 31: 882-883, 1999
35. Fellström B, Backman U, Larsson E, Zezina L: Immunologic and nonimmunologic risk factors of chronic rejection. Transplant Proc 31: 1304-1305, 1999
36. Tullius SG, Nieminen M, Bechtein WO, Jonas S, Qun Y, Rayes N, Pratschke, Volk HD, Tilney NL, Neuhaus P: Prompt treatment of initial acute rejection episodes may improve long-term graft outcome. Transpl Int 11: S3-S4, 1998
37. Tullius SG, Hancock WW, Heemann U, Azuma H, Tilney NL: Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation 58: 93-99, 1994
38. Zand MS, Li Y, Hancock W, Li XC, Roy-Chaudhury P, Zheng XX, Strom TB: Interleukin-2 and interferon-gamma double knockout mice reject heterotopiccardiac allografts. Transplantation 70: 1378-1381, 2000
39. Utans U, Arceci RJ, Yamashita Y, Russell ME: Cloning and characterization of allograft inflammatory factor-1: A novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 95: 2954-2962, 1995
40. Savinov AY, Wong FS, Chervonsky AV: IFN-gamma affects homing of diabetogenic T cells. J Immunol 167: 6637-6643, 2001